Variants in CAPN3 Causing Autosomal Dominant Limb–Girdle Muscular Dystrophy Combined With Calpain‐3 Deficiency
<b></b> Limb-girdle muscular dystrophy Type 2A/R1 or calpain-3 deficiency is the most common autosomal recessive limb-girdle muscular dystrophy. However, in recent years, autosomal dominant cases and families with calpain-3 deficiency have been reported, and there is an emerging interest in looking for single variants in the calpain-3 gene in mildly to moderately affected patients with limb-girdle muscular dystrophy without biallelic gene variants in <i>CAPN3</i>. Here, we report four cases with creatine kinase levels above 1500 U/L, mild-to-moderate proximal weakness, waddling gait, and scapular winging. Two patients, a son and his father, are heterozygous for the <i>CAPN3</i> variant c.304C>T; p.(Pro102Ser), which has previously been reported in patients with compound heterozygous variants in <i>CAPN3</i>. The third and fourth patients were heterozygous for c.1371C>G; p.(Asn457Lys) and c.1490C>T; p.Ala497_Glu508del, respectively, neither of which has been reported before. All four patients had a near-complete loss of calpain-3 as determined by western blotting. While inherited autosomal dominant calpainopathy has now been firmly established, additional single cases of dominant calpainopathy are likely to emerge; some will be associated with clinical findings from parents or siblings, while others will arise from spontaneous mutations, but nevertheless with similar clinical findings of mild-to-moderate proximal weakness, increased level of creatine kinase, and near-complete loss of calpain-3 protein in affected individuals. This report expands the known number of variants causing dominant calpainopathy from 8 to 11 that appears to exclusively reside in two out of four domains that make up calpain-3. This information could aid in determining whether a <i>CAPN3</i> variant of unknown significance is pathological.
Authors
- Edoardo Malfatti (ORCID: https://orcid.org/0000-0001-7871-8600)
- John Vissing (ORCID: https://orcid.org/0000-0001-6144-8544)
- Thomas Krag (ORCID: https://orcid.org/0000-0001-9330-668X)
- Mark A. Tarnopolsky (ORCID: https://orcid.org/0000-0003-0312-3746)
- Lauren Brady (ORCID: https://orcid.org/0000-0001-9587-471X)
- Camille Verebi (ORCID: https://orcid.org/0000-0002-0524-4827)
- Morten Dunø (ORCID: https://orcid.org/0000-0002-8436-7744)
- France Leturcq
- Emily Nasho (ORCID: https://orcid.org/0009-0004-9817-1533)
Institutions
- Inserm (FR)
- Paris-Est Sup (FR)
- McMaster University Medical Centre (CA)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Assistance Publique – Hôpitaux de Paris (FR)
- Génétique Médicale & Génomique Fonctionelle (FR)
- Institut Mondor de Recherche Biomédicale (FR)
Publication Details
- Journal
- Human Mutation
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/humu/9301465
- Citations
- 3
- Primary Topic
- Calpain Protease Function and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 3.45